Viewing Study NCT03273595


Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2026-02-22 @ 7:02 AM
Study NCT ID: NCT03273595
Status: UNKNOWN
Last Update Posted: 2017-09-06
First Post: 2017-02-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer
Sponsor: Xijing Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module